| ★ |  Osteoporosis in rare and complex connective tissue diseases | | 96 | — | |
| 1 |  Hydroxychloroquine in connective tissue diseases: benefits and controversial aspects | | 1.8K | — | 91 |
| 20 |  IgG4-related disease (IgG4-RD): update on diagnosis and treatments in 2025 | | 1.3K | — | 88 |
| 4 |  ERN ReCONNET: the New 2026 Webinar Series | | 630 | — | 90 |
| 11 |  Steroids in Relapsing Polychondritis | | 474 | — | 89 |
| 5 |  Quality of life in Relapsing Polychondritis (RP) | | 412 | — | 90 |
| 3 |  Why morning joint stiffness and swelling in rheumatic diseases? | | 398 | — | 90 |
| 13 |  Pregnancy in women with primary Sjögren’s disease | | 380 | — | 88 |
| 15 |  Update on B cell targeting therapies in IgG4-related disease | | 375 | — | 88 |
| 14 |  Exercise in adult idiopathic inflammatory myopathies (IIMs) | | 188 | — | 88 |
| 10 |  The transition from benign to secondary Raynaud’s phenomenon | | 186 | — | 89 |
| 7 |  Imaging in Relapsing Polychondritis (RP) | | 171 | — | 89 |
| 19 |  Everything you always wanted to know about Ehlers-Danlos Syndromes (EDS) – Part two | | 151 | — | 88 |
| 18 |  Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering | | 137 | — | 88 |
| 16 |  Unconventional therapies in connective tissue diseases | | 110 | — | 88 |
| 6 |  Vaccination in undifferentiated connective tissue disease (UCTD) | | 103 | — | 90 |
| 17 |  Unmet Needs in Childhood-Onset Sjögren's Disease – Patient and Clinician Perspectives | | 82 | — | 88 |
| 8 |  Pregnancy in undifferentiated connective tissue disease (UCTD) | | 72 | — | 89 |
| 12 |  Chat-GPT and more – how AI will revolutionize medicine and the management of rare diseases | | 71 | — | 89 |
| 9 |  Multidisciplinary diagnosis and team treatment in Idiopathic Inflammatory Myopathies | | 64 | — | 89 |
| 2 |  Genetic Testing in the Era of NGS: Lessons from the Hereditary Connective Tissue Disorders | | 35 | — | 91 |